Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI

Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI

Health Ministry permits the sale of Oseltamivir Phosphate and Zanamivir akin to Schedule H1 drugs, with restrictions on sale and export regulated by the Government and DCGI

by Anum Ahmed | Feb 12, 2024 | Central, OPS, Pharmaceuticals

Ministry of Health and Family Welfare has issued a Notification dated February 5, 2024, revoking... Read More

Public comments invited on proposed amendments to First and Second Schedule of the Drugs and Cosmetics Act till 12th April, 2023

Public comments invited on proposed amendments to First and Second Schedule of the Drugs and Cosmetics Act till 12th April, 2023

by Lexplosion | Feb 1, 2024 | Central, OPS, Pharmaceuticals

The Ministry of Ayush has invited objections and suggestions on proposed amendments to Schedule I... Read More

CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs

CDSCO issues FAQ for implementation Barcode requirement on the label of 300 brands of drugs

by Lexplosion | Aug 1, 2023 | Central, OPS, Pharmaceuticals

Central Drugs Standard Control Organization has issued a FAQ for implementation of the requirement... Read More

NPPA extends date for filing quarterly returns for quarter ended September, 2022 and MRP revisions of scheduled and non-scheduled drugs and medical devices till 31st December, 2022

NPPA extends date for filing quarterly returns for quarter ended September, 2022 and MRP revisions of scheduled and non-scheduled drugs and medical devices till 31st December, 2022

by Lexplosion | Nov 2, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

CDSCO issues a list of spurious, adulterated, misbranded, or non-standard quality drugs, medical devices and cosmetics for the month of September, 2022

by Lexplosion | Oct 21, 2022 | Central, OPS, Pharmaceuticals

You need to be logged in to view this content. Please Log In. Not a Member? Join... Read More

« Older Entries

Next Entries »